Max Theiler

Max Theiler was a doctor. He was born in South Africa. He studied how to fight sickness. He moved to the United States to do research.

Max worked on a bad sickness called yellow fever. He wanted to find a way to keep people safe. He worked with a team to make a tool. This tool was a vaccine.

He made a very weak version of the sickness. This weak version did not make mice sick. It helped them stay healthy instead. This was a big discovery.

His work helped stop the sickness for many people. He won a very big prize called the Nobel Prize. He was the first person from Africa to win it. Max helped the whole world.

Max Theiler was a doctor and a scientist. He was born in South Africa. He studied how to fight sickness. He moved to the United States to do research.

Max worked to stop a sickness called yellow fever. He wanted to make a vaccine. A vaccine is a tool that helps the body stay safe from germs. Max and his team used a special way to make it. They grew the virus in chicken embryos. An embryo is a tiny life inside an egg. They did this over 100 times.

They wanted to make a weak version of the virus. They named this weak version "17D." This weak virus did not kill mice. It helped them stay healthy. This meant the vaccine was safe.

Between 1940 and 1947, they made 28 million doses. This helped end yellow fever as a big sickness. For this work, Max won the Nobel Prize in 1951. He was the first person born in Africa to win it.

Max Theiler was a famous doctor and a scientist. He studied how tiny germs make people sick. He was born in Pretoria, South Africa, in 1899. His father was also a scientist who studied germs in animals. Max studied hard in South Africa and then in London. He wanted to spend his life doing research. He moved to the United States in 1922 to work at Harvard University.

Max worked very hard to stop a disease called yellow fever. This sickness was very dangerous to many people. He and his team wanted to create a vaccine. A vaccine is a way to teach the body to fight a specific germ. To do this, they needed a very weak version of the virus. They used a method where they grew the virus inside chicken embryos. An embryo is the tiny life growing inside an egg.

Making the vaccine was a very long and difficult job. Max and his colleague Hugh Smith worked with the virus for a long time. They had to grow the virus in chicken embryos more than 100 times. They wanted to find a version that would not kill mice. Finally, in 1937, they found a safe, weak version. They gave this version the name "17D." This version helped animals stay safe from the real disease.

This new vaccine changed the world for many people. Between 1940 and 1947, the Rockefeller Foundation made over 28 million doses. This helped end yellow fever as a major disease. Because of his great work, Max won the Nobel Prize in 1951. This is a very special award for scientists. He was the first person born in Africa to win this prize.

Max also discovered another virus in mice in 1937. Scientists now call this "Theiler's murine encephalomyelitis virus." It is a very important tool for modern science. Researchers use it to study a condition called multiple sclerosis. Max lived a full life and worked at Yale University later on. He died in 1972 in Connecticut. His work still helps doctors and scientists today.

Max Theiler was a highly influential virologist and physician. He dedicated his career to studying viruses and how they affect living things. A virologist is a scientist who specializes in the study of viruses. Theiler was born in Pretoria, South Africa, on January 30, 1899. His father, Arnold Theiler, was a veterinary bacteriologist who studied bacteria in animals. This background in science likely influenced Max's own career path. He became a pioneer in the field of tropical medicine. His most famous achievement was creating a vaccine to fight yellow fever.

To understand his work, one must understand the process of attenuation. Attenuation is the process of making a virus weaker so it cannot cause serious disease. Theiler wanted to create a vaccine that would teach the immune system to fight yellow fever without making the person sick. He began by passing the yellow fever virus through laboratory mice. He discovered that this weakened version could provide immunity to rhesus macaques. These are a specific type of Old World monkey. He also developed a specific test to check if vaccines were working. This was called the mouse protection test. In this test, scientists injected sera, which is the clear part of blood, from vaccinated humans into mice. They then observed if the mice were protected from the virus.

Developing the 17D vaccine was a complex, multi-step process. Theiler and his colleague Hugh Smith used a technique involving chicken embryos. An embryo is the early stage of a developing organism inside an egg. They used the particularly virulent Asibi strain from West Africa. A virulent strain is one that is very strong and causes severe disease. The team sought to obtain an attenuated strain that would not kill mice when injected into their brains. This required a massive amount of repetitive work. They performed more than 100 subcultures in chicken embryos. A subculture is the process of growing a sample in a new environment. Finally, in 1937, they successfully obtained the 17D strain. This mutant strain was both safe and capable of immunizing animals.

Max Theiler's career was marked by many important scientific discoveries. In 1926, while working at the Harvard University School of Tropical Medicine, he helped disprove a major hypothesis. A scientist named Hideyo Noguchi had believed yellow fever was caused by a bacterium called Leptospira icteroides. Theiler and his assistant, Andrew Sellards, proved this was incorrect. In 1928, they also showed that African and South American viruses were immunologically identical. This means the viruses reacted to the immune system in the same way. During this research, Theiler actually contracted yellow fever himself. He survived the illness and developed natural immunity. He later moved to New York in 1930 to lead the Virus Laboratory at the Rockefeller Foundation.

The impact of the 17D vaccine was enormous and measurable. After the vaccine was developed, the Rockefeller Foundation began human trials in South America. Between 1940 and 1947, the foundation produced more than 28 million doses of the vaccine. This massive production effort helped end yellow fever as a major disease. For this incredible contribution to global health, Theiler was awarded the Nobel Prize in Physiology or Medicine in 1951. He was the first person born in Africa to receive this prestigious honor. He also received several other awards. These included the Chalmers Medal in 1939 and the Lasker Award in 1949.

Beyond yellow fever, Theiler made another significant discovery in 1937. He identified a filterable agent that caused paralysis in mice. This agent is now known as Theiler's murine encephalomyelitis virus. He noted that this specific virus was not transmittable to rhesus macaques. He also observed that only certain mice would develop symptoms. This discovery remains highly relevant to modern medical research. Today, the virus serves as a standard model for scientists studying multiple sclerosis. Multiple sclerosis is a condition that affects the central nervous system. By using this virus, researchers can better understand how such diseases work.

The life of Max Theiler connects many different fields of science. His work bridged the gap between veterinary science, virology, and public health. He served as a professor of epidemiology and public health at Yale University. Epidemiology is the study of how diseases spread and can be controlled. He also contributed to several important scientific books. These publications helped document the history of viral research and the work of the Rockefeller Foundation. Theiler lived in the United States for most of his life after moving from South Africa. He died on August 11, 1972, in New Haven, Connecticut. His legacy lives on through the millions of lives saved by his vaccine.